See also this year's filing and all EDGAR filings for this company.
PDF Report 0000034956_2014_Tenax_Therapeutics_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000034956, Tenax Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,842,251 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 924,698 |
| 2 | PropertyPlantAndEquipmentNet | 205,389 |
| 3 | remainder_Assets | 208,305 |
| 4 | LiabilitiesCurrent | 1,909,577 |
| 5 | LiabilitiesNoncurrent | 54,660 |
| 6 | remainder_Liabilities | 2,994,442 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,676,145 |
| 9 | ResearchAndDevelopmentExpense | 2,455,816 |
| 10 | remainder_Expenses | 4,486,450 |
| 11 | remainder_Revenues | 1,190,928 |
| 12 | remainder_NetIncome | 11,683 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,180,643 |
| 1 | Liabilities | 4,958,679 |
| 2 | Expenses | 10,618,411 |
| 3 | Revenues | 1,190,928 |
| 4 | StockholdersEquity | -1,778,036 |
| 5 | NetIncome | -9,415,800 |
| 6 | ComprehensiveNetIncome | -9,415,800 |
| 7 | BaseVar | 9,980,172 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.27 |
| 9 | EconomicCapitalRatio | 0.601 |
Edgar->Model Mapping
Feature Distribution
Change over Time
